Investor Presentaiton

Building a unique platform for global leadership in our attractive high growth markets with large network effects * eurofins High barriers to entry exist in Eurofins' markets. Significant investments are required to build and efficiently run modern laboratories. Clients seldom change laboratory supplier. Constant scientific breakthroughs lead to novel equipment and testing methods. Methods often take years to be developed and validated Clients increasingly expect a complete range of tests - Food testing is over 130,000 validated tests already. Stickiness of business. Switching costs are high. Clients often have decade-long stable relationships with their laboratory of choice. Bioanalytical testing is a highly scalable activity Economies of scale in testing and logistics are huge and create a large cost advantage for the market leader vs. competitors. In order to unlock economies of scope and scale, a global standardized network of laboratories is needed • Developing a state-of-the-art global laboratory network takes decades and requires very large investments: Advanced bespoke IT solutions are required to offer a one-stop-shop for clients around the globe providing them access to the full range of services offered by all laboratories in the network Automation, artificial intelligence (AI) and proprietary reagents and methods are very expensive and these investments require large scale to be justified. Eurofins' 2020 growth plan, aimed at building a leading one of a kind global laboratories platform in its chosen high growth markets, is well underway For over 15 years, Eurofins has been consistently investing more than its peers to develop a hard-to-replicate network of laboratories and a very broad portfolio of advanced bio-analytical tests and more non time critical tests to its large hub labs. These large investments, aimed at long-term value creation, impact Eurofins' short term cash flow generation and margins Between 2010 and 2020, Eurofins developed one-of-a-kind 'hub and spoke' laboratory infrastructure for its leading markets by consolidating less efficient and smaller sites into large, high-throughput Centres of Excellence (or 'hubs'), in order to unlock the potential of economies of scale and the large cost advantage available to the market leader vs. competitors. Eurofins has invested much more than its peers in its unique network of laboratories and state-of-the-art IT solutions, putting its growth plan to develop market leadership platform well into motion. Looking beyond 2020, when Eurofins' five-year growth phase will have completed in 2021, the Group believes it will be well placed to leverage these market leadership positions, in combination with its global network of laboratories, scale and scientific excellence, to significantly improve its cash flow generation and profitability to create further significant value. 34

View entire presentation